‘Downturn an opportunity for biotech scientists’

He said it is difficult to predict the outcome of this downturn but it has had an impact on the money people spend on health and medical treatment. Investing in biotechnology can be an answer to this difficult time as it has a huge potential to create jobs. If India becomes self sufficient in biotechnology,we can do away with import pressures of nearly Rs 3000 crore,he said.

“India has a strong potential to produce low cost medicines and this can help us progress fast. India has a suitable climate for cell and bacteria development. We need to change the scene from profitable chemical drugs manufacturing to profitable biotechnology.

I-Square IT’s founder director Dr Vijay Bhatkar said,”India is among the youngest nations in the world as the average age of an Indian is 25. India has a strong chance to lead global progress in the current century.

“But being young alone is not enough; we must combine education,training,industry and ambition. Modern technolologies like IT,management,nano tech and so on are converging. We should adopt stem cell technology in this favourable background.”